Category: Politics and Regulation
FDA should pull the plug on thermography
The FDA says there's no good evidence that thermography can reliably screen for breast cancer or any other disease. Instead of pursuing the unlawful promotion of thermography for breast cancer detection on a case-by-case basis, the FDA should pull the plug on thermographic devices.
FDA: No CBD in dietary supplements or foods for now, but let’s talk
The FDA reminds everyone that (no matter what your state says) CBD is not a legal ingredient in dietary supplements and foods. The agency is willing to explore changes to the law but unproven claims for CBD health benefits, such cancer cures, will not be tolerated.
Maine considers protecting quacks from accountability to regulators and patients
The Maine Legislature is considering a bill that would put quacks beyond the reach of state healthcare regulatory authorities and leave patients without effective redress for harms.
New FDA rule cracks down on compounded drug ingredients
A new FDA rule will require evidence of safety and effectiveness for substances used in compounded drugs, alarming naturopaths and integrative physicians. Experts have recommended that a number of naturopathic compounding favorites be banned.
Australia’s Chiropractic Board bans spinal manipulation for children under two pending evidence review
Chiropractic Board of Australia interim policy prohibits spinal manipulation of children under two years old pending expert review of evidence by health authorities. Given the lack of evidence supporting chiropractic treatment of children, it should be banned.
Experts slam CAM lab tests, call for better regulation
Experts review the evidence and find that common CAM lab tests have "little or no clinical benefit" and are "a potential risk to patient safety." Regulatory reform is urgently needed to protect the public.
Drug maker challenges FDA on animal testing
A drug maker claims an FDA-required toxicity study in animals is unnecessary to determine safety and urges others to question the routine use of animal testing.
FDA promises industry-friendly “modernization” of dietary supplement regulation
The FDA promises the "most significant modernization of dietary supplement regulation" in 25 years while maintaining its industry-friendly regulatory scheme.

